Author

Anaïs Dubiau

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

Garrett Marc DancikiD· 1 shared Lamia MadaciiD· 1 shared Régis T. CostelloiD· 1 shared Spiros VlahopoulosiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Garrett Marc DancikORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic & Genomic MedicineCellsPeer-reviewedJul 7, 2025

RNA expression data suggest ALDH2 inhibition as a concept for killing acute myeloid leukemia cells that are resistant to ALDH1 inhibitors: the example of NPM1 mutant AML

Régis T. Costello, Garrett Marc Dancik, Anaïs Dubiau…·Spiros Vlahopoulos

The paper analyzes RNA expression data to show that ALDH2 is more prognostically significant than ALDH1A1 in NPM1 mutant AML, suggesting ALDH2 inhibition as a potential therapeutic strategy.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky